0,568€
3,65%
Echtzeit-Aktienkurs MESOBLAST LTD.
Bid:
Ask:
Echtzeit-Chart der MESOBLAST LTD. Aktie
Börsenkurse MESOBLAST LTD.
Echtzeit Euro | - | - | - | - | 0,575€ | 3,14% |
gettex | - | - | - | - | 0,565€ | 3,10% |
Tradegate | - | - | - | - | 0,568€ | 3,65% |
Börse Stuttgart | - | - | - | - | 0,550€ | 1,85% |
Profil der MESOBLAST LTD. Aktie
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.